Danaher (NYSE:DHR)‘s stock had its “hold” rating reiterated by analysts at Royal Bank of Canada in a report issued on Wednesday, January 31st. They presently have a $98.00 price target on the conglomerate’s stock. Royal Bank of Canada’s price target points to a potential upside of 3.75% from the stock’s previous close.
Several other research firms also recently issued reports on DHR. Cowen restated a “buy” rating and set a $110.00 price objective on shares of Danaher in a report on Tuesday, January 30th. Credit Suisse Group lifted their target price on Danaher from $99.00 to $105.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Morgan Stanley lifted their target price on Danaher from $103.00 to $110.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 31st. Stifel Nicolaus lifted their target price on Danaher from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Wednesday, January 31st. Finally, UBS Group started coverage on Danaher in a research report on Monday, January 22nd. They issued a “buy” rating and a $99.97 target price for the company. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. Danaher has an average rating of “Buy” and a consensus target price of $100.13.
Shares of Danaher (NYSE DHR) traded up $2.30 during trading hours on Wednesday, hitting $94.46. The company had a trading volume of 3,684,046 shares, compared to its average volume of 2,870,000. The stock has a market cap of $65,710.00, a P/E ratio of 26.99, a P/E/G ratio of 1.99 and a beta of 1.04. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.39. Danaher has a 1-year low of $78.97 and a 1-year high of $104.82.
Danaher (NYSE:DHR) last announced its earnings results on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, beating the consensus estimate of $1.16 by $0.03. The business had revenue of $5.09 billion for the quarter, compared to the consensus estimate of $4.97 billion. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The company’s revenue was up 10.9% on a year-over-year basis. During the same period last year, the business posted $1.05 EPS. equities research analysts expect that Danaher will post 4.37 EPS for the current year.
In other Danaher news, SVP Daniel Raskas sold 37,870 shares of the business’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $93.33, for a total transaction of $3,534,407.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Angela S. Lalor sold 42,988 shares of the business’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $102.29, for a total value of $4,397,242.52. Following the transaction, the senior vice president now owns 82,008 shares of the company’s stock, valued at approximately $8,388,598.32. The disclosure for this sale can be found here. Insiders have sold a total of 274,913 shares of company stock valued at $27,729,293 in the last quarter. 12.20% of the stock is currently owned by insiders.
Several institutional investors and hedge funds have recently bought and sold shares of the company. First Republic Investment Management Inc. raised its position in shares of Danaher by 0.9% during the fourth quarter. First Republic Investment Management Inc. now owns 543,783 shares of the conglomerate’s stock worth $50,474,000 after purchasing an additional 4,904 shares during the period. Dragon Financial & Investment Group LLC acquired a new stake in shares of Danaher during the fourth quarter worth $232,000. Mission Wealth Management LP raised its position in shares of Danaher by 8.7% during the fourth quarter. Mission Wealth Management LP now owns 11,546 shares of the conglomerate’s stock worth $1,072,000 after purchasing an additional 920 shares during the period. GM Advisory Group Inc. acquired a new stake in shares of Danaher during the fourth quarter worth $218,000. Finally, Norinchukin Bank The raised its position in shares of Danaher by 2.3% during the fourth quarter. Norinchukin Bank The now owns 151,475 shares of the conglomerate’s stock worth $14,060,000 after purchasing an additional 3,445 shares during the period. 76.19% of the stock is currently owned by institutional investors.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.